Screener
Beam Therapeutics BEAM Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Beam Therapeutics’s 10-Q, filed November 4, 2025. Open the filing →
- Filed
- Nov 4, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-263542
FAQ
- What is Beam Therapeutics's net margin?
- Beam Therapeutics (BEAM) reported net margin of -742.7% in Q3 2025.
- What is the long-term trend for Beam Therapeutics's net margin?
- Over 3 years (2020 to 2024), Beam Therapeutics's net margin has grown at a -91.0% compound annual growth rate (CAGR), from -810,800% to -593.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Beam Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude